ArticleIn vivo (Athens, Greece)

Anti-Tumor and Chemosensitizing Effects of the CDK Inhibitor Dinaciclib on Cholangiocarcinoma

Prin Sungwan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.